Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7977837rdf:typepubmed:Citationlld:pubmed
pubmed-article:7977837lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7977837lifeskim:mentionsumls-concept:C0034705lld:lifeskim
pubmed-article:7977837lifeskim:mentionsumls-concept:C0344315lld:lifeskim
pubmed-article:7977837lifeskim:mentionsumls-concept:C0080309lld:lifeskim
pubmed-article:7977837lifeskim:mentionsumls-concept:C0055723lld:lifeskim
pubmed-article:7977837pubmed:issue5 Pt 2lld:pubmed
pubmed-article:7977837pubmed:dateCreated1994-12-8lld:pubmed
pubmed-article:7977837pubmed:abstractTextThe purpose of this study was to characterize the effect of chronic treatment with an angiotensin-converting enzyme (ACE) inhibitor on left ventricular function in spontaneously hypertensive rats (SHR). Cilazapril (5 mg/kg) was administered in the drinking water continuously for 11 wk, beginning at 4 wk of age. Systolic arterial pressure (SAP) was monitored weekly. At the end of the 11-wk period, left ventricular function was quantified using the perfused working heart preparation. Cilazapril exerted a rapid, complete, and persistent antihypertensive effect in the SHR in vivo but had no effect on SAP in the normotensive Sprague-Dawley (S-D) group. Nevertheless, the drug reduced left ventricular weight to the same extent in both strains. Function of untreated SHR hearts was not different from that of the untreated S-D hearts. Cilazapril treatment depressed heart performance (28-35%) in SHR but had no effect in the S-D group. The decline in pump performance in SHR hearts was associated with diminished tension development and velocity of shortening of papillary muscles. These results demonstrate that an ACE inhibitor, administered to young SHR, produces a reduction in left ventricular contractile function, which may be due to a decline in muscle contractility and which cannot be explained exclusively by the reduction in left ventricular mass.lld:pubmed
pubmed-article:7977837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7977837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7977837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7977837pubmed:languageenglld:pubmed
pubmed-article:7977837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7977837pubmed:citationSubsetIMlld:pubmed
pubmed-article:7977837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7977837pubmed:statusMEDLINElld:pubmed
pubmed-article:7977837pubmed:monthNovlld:pubmed
pubmed-article:7977837pubmed:issn0002-9513lld:pubmed
pubmed-article:7977837pubmed:authorpubmed-author:AnversaPPlld:pubmed
pubmed-article:7977837pubmed:authorpubmed-author:CapassoJ MJMlld:pubmed
pubmed-article:7977837pubmed:authorpubmed-author:LiPPlld:pubmed
pubmed-article:7977837pubmed:authorpubmed-author:RodgersR LRLlld:pubmed
pubmed-article:7977837pubmed:authorpubmed-author:ChristeM EMElld:pubmed
pubmed-article:7977837pubmed:authorpubmed-author:PerrettaA AAAlld:pubmed
pubmed-article:7977837pubmed:issnTypePrintlld:pubmed
pubmed-article:7977837pubmed:volume267lld:pubmed
pubmed-article:7977837pubmed:ownerNLMlld:pubmed
pubmed-article:7977837pubmed:authorsCompleteYlld:pubmed
pubmed-article:7977837pubmed:paginationH2050-7lld:pubmed
pubmed-article:7977837pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:meshHeadingpubmed-meshheading:7977837-...lld:pubmed
pubmed-article:7977837pubmed:year1994lld:pubmed
pubmed-article:7977837pubmed:articleTitleCilazapril treatment depresses ventricular function in spontaneously hypertensive rats.lld:pubmed
pubmed-article:7977837pubmed:affiliationDepartment of Pharmacology and Toxicology, University of Rhode Island, Kingston 02881.lld:pubmed
pubmed-article:7977837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7977837pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7977837pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7977837pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7977837pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7977837lld:pubmed